Vaccinex (VCNX) Institutional Ownership $0.79 -0.03 (-3.66%) As of 08/1/2025 01:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Vaccinex (NASDAQ:VCNX)CurrentInstitutional OwnershipPercentage50.11%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$496.49KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$330.99K Get VCNX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaccinex stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VCNX Institutional Buying and Selling by Quarter Vaccinex Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024Point72 Asset Management L.P.166,000$564K0.0%+42.4%9.595% 8/15/2024Armistice Capital LLC94,000$610K0.0%-35.2%5.934% 8/7/2024 AIGH Capital Management LLC108,958$707K0.2%+86.7%6.896% 2/12/2024 AIGH Capital Management LLC817,061$543K0.2%-25.1%6.542% 2/9/2024Worth Venture Partners LLC654,079$435K0.2%-8.8%5.237% 11/15/2023Worth Venture Partners LLC717,559$811K0.5%+417.0%16.308% 11/15/2023Armistice Capital LLC680,000$768K0.0%N/A15.455% 11/13/2023 AIGH Capital Management LLC1,090,173$1.23M0.6%-19.4%24.777% 5/15/2023 AIGH Capital Management LLC951,801$380K0.1%-61.2%1.735% 5/1/2023Virtu Financial LLC103,898$42K0.0%N/A0.189% Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 2/16/2023 AIGH Capital Management LLC2,451,801$1.66M0.5%+17.8%4.915% 5/12/2022 AIGH Capital Management LLC2,081,801$2.63M0.6%N/A4.880% 11/16/2021Telemetry Investments L.L.C.132,500$286K0.4%+10.4%0.430% 11/15/2021Natixis31,895$69K0.0%N/A0.104% 11/12/2021 Oppenheimer & Co. Inc.31,751$69K0.0%-24.3%0.103% 9/17/2021Virtu Financial LLC38,026$106K0.0%+103.9%0.123% 8/16/2021Point72 Asset Management L.P.395,522$1.11M0.0%N/A1.390% 8/16/2021Telemetry Investments L.L.C.120,000$336K0.5%+14.3%0.422% 8/16/2021State Street Corp67,200$188K0.0%N/A0.236% 8/13/2021Geode Capital Management LLC104,114$291K0.0%+59.4%0.366% 8/13/2021Vanguard Group Inc.600,624$1.68M0.0%+145.9%2.111% 5/19/2021Virtu Financial LLC18,652$56K0.0%N/A0.066% 5/17/2021Goldman Sachs Group Inc.20,447$61K0.0%-41.9%0.072% 5/13/2021Bank of New York Mellon Corp17,954$54K0.0%N/A0.063% 5/12/2021Geode Capital Management LLC65,331$194K0.0%N/A0.230% (Data available from 1/1/2016 forward) VCNX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VCNX shares? During the previous two years, the following institutional investors and hedge funds held shares of Vaccinex shares: AIGH Capital Management LLC ($707K), Armistice Capital LLC ($610K), and Point72 Asset Management L.P. ($564K), Worth Venture Partners LLC ($435K).Learn more on Vaccinex's institutional investors. What percentage of Vaccinex's stock is owned by institutional investors? 50.11% of Vaccinex's stock is owned by institutional investors. Learn more on VCNX's institutional investor holdings. Which institutional investors have been buying Vaccinex's stock? The following institutional investors have purchased Vaccinex's stock in the last 24 months: Armistice Capital LLC ($680K), Worth Venture Partners LLC ($578.76K), AIGH Capital Management LLC ($50.59K), and Point72 Asset Management L.P. ($49.45K). How much institutional buying is happening at Vaccinex? Institutional investors have bought a total of 100,047 shares in the last 24 months. This purchase volume represents approximately $496.49K in transactions. Which of Vaccinex's major shareholders have been selling company stock? The following institutional investors have sold Vaccinex stock in the last 24 months: Armistice Capital LLC ($51K). How much institutional selling is happening at Vaccinex? Institutional investors have sold a total of 51,000 shares in the last 24 months. This volume of shares sold represents approximately $330.99K in transactions. Related Companies KZIA Institutional Ownership SNSE Institutional Ownership IMNN Institutional Ownership KPRX Institutional Ownership LSB Institutional Ownership MBIO Institutional Ownership DWTX Institutional Ownership APRE Institutional Ownership GNPX Institutional Ownership AEON Institutional Ownership This page (NASDAQ:VCNX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.